Artificial intelligence augmenting medical management
OP36: A colonic gene expression signature predicts nonresponse to anti-inflammatory therapies in Inflammatory Bowel Disease
Robot and surgeon: How will a partnership work?
OP37: Efficacy and safety of ustekinumab as maintenance therapy in Ulcerative Colitis: Week 44 results from UNIFI
OP38: Maintenance treatment with mirikizumab, a p19-directed IL-23 antibody: 52-week results in patients with Moderately to Severely Active Ulcerative Colitis
Big data: Potential for transforming IBD research and care